Skip to main content
. Author manuscript; available in PMC: 2022 May 31.
Published in final edited form as: Bioconjug Chem. 2021 Jun 22;32(8):1554–1558. doi: 10.1021/acs.bioconjchem.1c00280

FIGURE 1.

FIGURE 1.

Scheme for host-guest pretargeted nuclear medicine imaging: (1) administration of a cucurbit[7]uril (CB7) modified antibody, (2) administration of the ferrocene (Fc) radioligand several days later and (3) the imaging is performed hours after the radioligand injection.